BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6108019)

  • 1. [Effect of obsidan on the dynamics of the myocardial infarct zone in the 1st days of the disease].
    Ivanova LK
    Vrach Delo; 1980 Oct; (10):15-8. PubMed ID: 6108019
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inderal in the acute and post-myocardial infarct periods].
    Popov VG; Martynov IV; Alushkov MV; Voronin VA
    Ter Arkh; 1986; 58(6):53-8. PubMed ID: 3764715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of beta-adrenoblockaders in myocardial infarct].
    Korabel'shchikova NI; Kashshai AA; Pichkar' II
    Vrach Delo; 1981 Dec; (12):38-41. PubMed ID: 6120597
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemodynamic reactions to the use of beta-adrenoblockaders in acute myocardial infarct].
    Golikov AP; Maĭorov NI; Vaniev SB; Orlov AI
    Vrach Delo; 1980 Nov; (11):33-5. PubMed ID: 6110282
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the effects of a beta-blocking drug (moprolol) on hemodynamics and lesion potentials in acute myocardial infarct].
    De Ambroggi L; Perotta GM; Satolli R; Lotto A
    Boll Soc Ital Cardiol; 1977; 22(8):1343-51. PubMed ID: 36116
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience with using obzidan in myocardial infarct].
    Kuznetsov GP; Gligan LI; Zil'berman ES; Gubanova TG; Fel'dman MS
    Klin Med (Mosk); 1984 Mar; 62(3):35-8. PubMed ID: 6716927
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of beta blockers on the parameters of acute phase response and level of circulating immune complexes in myocardial infarct].
    Korochkin IM; Chukaeva II; Aleshkin AV; Smolina NV; Litvinova SN; Aleksandrov AA
    Sov Med; 1991; (6):45-7. PubMed ID: 1716007
    [No Abstract]   [Full Text] [Related]  

  • 8. [Improved prognosis using beta blockers after myocardial infarct?].
    Weisswange A
    Lebensversicher Med; 1984 Jan; 36(1):14-9. PubMed ID: 6141479
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of obzidan on cell membrane permeability in myocardial infarct patients].
    Parkhomenko AN; Netiazhenko VZ; Angelutsa PA
    Vrach Delo; 1985 Aug; (8):16-9. PubMed ID: 4072104
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beta blockage after myocardial infarct].
    Frick MH; Katila M
    Duodecim; 1982; 98(2):150-7. PubMed ID: 6120827
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanisms of the effect of obsidan on the clinical picture of myocardial infarction at the early stage of the disease].
    Andriushchenko OM
    Klin Med (Mosk); 1989 Oct; 67(10):48-51. PubMed ID: 2615306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction].
    Halawa B; Mazurek W
    Wiad Lek; 1986 Jan; 39(1):25-30. PubMed ID: 2872756
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic potential of beta-receptor blockers in acute anterior wall infarct].
    Jentsch G
    MMW Munch Med Wochenschr; 1982 Jun; 124(22):543-4. PubMed ID: 6124886
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epidural analgesia with obzidan in the acute period of myocardial infarct].
    Parkhomenko AN; Netiazhenko VZ; Sirenko IuN
    Vrach Delo; 1989 Dec; (12):10-3. PubMed ID: 2629262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of beta adrenergic blocking agents in the management of the patient with acute myocardial infarction.
    Arensberg D
    Prim Care; 1981 Sep; 8(3):461-6. PubMed ID: 6118904
    [No Abstract]   [Full Text] [Related]  

  • 16. [Obzidan inhibition of lipid free-radical peroxidation in coronary-occluding myocardial infarct].
    Luk'ianova LO; Kudrin AN; Kogan AKh
    Farmakol Toksikol; 1983; 46(1):45-8. PubMed ID: 6825817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The objective assessment of treatment efficacy in microfocal myocardial infarct using paired stress tests].
    Tashchuk VK; Polishchuk OIu; Hrechko SI; Makoviĭchuk IO; Polians'ka OS; Turubarova NA; Chaplyns'kyĭ RB; Sokur IV
    Lik Sprava; 1998 Aug; (6):84-6. PubMed ID: 9844883
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of obzidan in the acute period of myocardial infarct].
    Gvatua NA; Kravtsov VL; Ivanova LK; Shkliar LV; Shumakov VA
    Kardiologiia; 1980 Oct; 20(10):19-24. PubMed ID: 7441957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of labetalol and propranolol in patients who have had a myocardial infarct].
    Il'iash MG; Kravtsova LA; Babov KD; Shcherbak IaIu
    Vrach Delo; 1990 May; (5):26-8. PubMed ID: 2396387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional features of acute non-Q-wave myocardial infarction and the influence of pre-hospital treatment with propranalol, heparin and aspirin on the prognosis of the disease].
    Beĭshenkulov MT; Kudaĭbergenova NT; Baltabaev TB
    Klin Med (Mosk); 2005; 83(1):28-32. PubMed ID: 15759487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.